5101 – 5110 of 7659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array-comparative genomic hybridization
(
- Contribution to journal › Article
-
Mark
Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours
2010) 35th European-Society-for-Medical-Oncology (ESMO) Congress In Annals of Oncology 21(Suppl. 8). p.177-178(
- Contribution to journal › Published meeting abstract
-
Mark
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
(
- Contribution to journal › Article
-
Mark
Impact of Lifestyle, Hormones, and Genes on Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Genomic profiling of breast cancer by microarray-based technology and bioinformatics
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
(
- Contribution to journal › Article
-
Mark
Vitamins B2 and B6 and Genetic Polymorphisms Related to One-Carbon Metabolism as Risk Factors for Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Gene Expression Profile of Colon Cancer Cell Lines Treated with SN-38
(
- Contribution to journal › Article
-
Mark
Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
(
- Contribution to journal › Article
-
Mark
Vandetanib In Locally Advanced Or Metastatic Differentiated Thyroid Cancer (Papillary Or Follicular; Dtc): A Randomized, Double-Blind Phase Ii Trial
2010) 35th European-Society-for-Medical-Oncology (ESMO) Congress In Annals of Oncology 21. p.315-315(
- Contribution to journal › Published meeting abstract